No takes yet. Share an insight, caveat, or question.
Analysis reveals critical regulatory compliance and cold-chain management issues in U.S. pharmaceutical supply chains, highlighting strategies for improved resiliency.
Gupta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: